Patents by Inventor Kathy Mason

Kathy Mason has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Selective accretion of cytoprotectant in radiation-sensitive tissues and uses thereof
    Patent number: 11478489
    Abstract: The disclosure relates to the treatment of primary and metastatic cancer using radiation. Specifically, the disclosure relates to methods providing for the selective accretion of cytoprotective agent in tissues and/or organs, sensitive to radiation that are adjacent to malignant tumors prior to radiation of the tumors at a dose that otherwise would be toxic to the tissues and/or organs, but are necessary to achieve ablative outcome on the tumors.
    Type: Grant
    Filed: November 19, 2018
    Date of Patent: October 25, 2022
    Assignees: WILLIAM MARSH RICE UNIVERSITY, THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY, BOARD OF REGENTS, UNIVERSITY OF TEXAS SYSTEM
    Inventors: James Tour, Cullen Taniguchi, Kathy Mason
  • SELECTIVE ACCRETION OF CYTOPROTECTANT IN RADIATION-SENSITIVE TISSUES AND USES THEREOF
    Publication number: 20200360406
    Abstract: The disclosure relates to the treatment of primary and metastatic cancer using radiation. Specifically, the disclosure relates to methods providing for the selective accretion of cytoprotective agent in tissues and/or organs, sensitive to radiation that are adjacent to malignant tumors prior to radiation of the tumors at a dose that otherwise would be toxic to the tissues and/or organs, but are necessary to achieve ablative outcome on the tumors.
    Type: Application
    Filed: November 19, 2018
    Publication date: November 19, 2020
    Applicants: WILLIAM MARSH RICE UNIVERSITY, THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY, BOARD OF REGENTS, UNIVERSITY OF TEXAS SYSTEM
    Inventors: James Tour, Cullen Taniguchi, Kathy Mason
  • Water-soluble carbon nanotube compositions for drug delivery and medicinal applications
    Patent number: 8784866
    Abstract: Compositions comprising a plurality of functionalized carbon nanotubes and at least one type of payload molecule are provided herein. The compositions are soluble in water and PBS in some embodiments. In certain embodiments, the payload molecules are insoluble in water. Methods are described for making the compositions and administering the compositions. An extended release formulation for paclitaxel utilizing functionalized carbon nanotubes is also described.
    Type: Grant
    Filed: October 3, 2008
    Date of Patent: July 22, 2014
    Assignees: William Marsh Rice University, Board of Regents, The University of Texas System
    Inventors: James M. Tour, Rebecca Lucente-Schultz, Ashley Leonard, Dmitry V. Kosynkin, Brandi Katherine Price, Jared L. Hudson, Jodie L. Conyers, Jr., Valerie C. Moore, S. Ward Casscells, Jeffrey N. Myers, Zvonimir L. Milas, Kathy A. Mason, Luka Milas
  • WATER-SOLUBLE CARBON NANOTUBE COMPOSITIONS FOR DRUG DELIVERY AND MEDICINAL APPLICATIONS
    Publication number: 20090170768
    Abstract: Compositions comprising a plurality of functionalized carbon nanotubes and at least one type of payload molecule are provided herein. The compositions are soluble in water and PBS in some embodiments. In certain embodiments, the payload molecules are insoluble in water. Methods are described for making the compositions and administering the compositions. An extended release formulation for paclitaxel utilizing functionalized carbon nanotubes is also described.
    Type: Application
    Filed: October 3, 2008
    Publication date: July 2, 2009
    Applicant: William Marsh Rice University
    Inventors: James M. Tour, Valerie C. Moore, S. Ward Casscella, Jeffrey N. Myers, Zvonimir L. Milas, Kathy A. Mason, Luka Milas, Brandl Katherine Price, Jared L. Hudson, Jodie L. Conyers, JR., Rebecca L. Lucente-Schultz, Ashley Leonard, Dmitry V. Kosynkin